As part of a collective effort in fighting COVID-19, ImmunoScape is collaborating with Arcturus Therapeutics, a developer of RNA therapeutics for treatment and prevention of diseases with high unmet medical needs, and Duke-NUS, who will be running the clinical trial...
The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines PDF Version SINGAPORE and SAN DIEGO, August 12, 2020, /PRNewswire/ —...
immunoSCAPE has the technology to deeply profile multifaceted T cell responses during pathogen infection that may be important for defining both the correlates of protective immunity, and to also identify potentially protective epitopes for incorporation into...
The Straits Times recently interviewed ImmunoScape executives to learn about their current global collaborations to help understand the immune response to Covid-19 and how they can aid vaccine development.